| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
B Is Tumor Promoting but Does Not Substitute for Loss of p53
1 Tumor Cell Death Laboratory and 2 Tumor Suppression Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Glasgow, United Kingdom, and 3 Regulation of Cell Growth Laboratory, National Cancer Institute at Frederick, Frederick, Maryland
Inactivation of apoptotic pathways is a common event in cancer. Two transcription factors that regulate apoptosis during tumorigenesis are p53 and nuclear factor (NF)-
B. Although NF-
B is generally considered a suppressor of cell death, we showed previously that NF-
B can contribute to p53-induced death. Here, we show that loss of p65, a critical subunit of NF-
B, can cause resistance to different agents that signal death through p53. Loss of p65 also enhances tumorigenesis induced by E1a and Ras. Unlike loss of p53, however, loss of p65 does not cause anchorage-independent growth or enable tumor development following expression of a single oncogene. These findings reaffirm the role of NF-
B in p53-induced death but show that its loss does not substitute for loss of p53 in tumor development. Moreover, this indicates that, although perhaps central to p53 function, loss of the ability to induce programmed cell death does not completely inactivate p53s tumor-suppressive effects.
This article has been cited by other articles:
![]() |
T. Copetti, C. Bertoli, E. Dalla, F. Demarchi, and C. Schneider p65/RelA Modulates BECN1 Transcription and Autophagy Mol. Cell. Biol., May 15, 2009; 29(10): 2594 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Minsavage and J. F. Dillman III Bifunctional Alkylating Agent-Induced p53 and Nonclassical Nuclear Factor {kappa}B Responses and Cell Death Are Altered by Caffeic Acid Phenethyl Ester: A Potential Role for Antioxidant/Electrophilic Response-Element Signaling J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 202 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Gurova, J. E. Hill, C. Guo, A. Prokvolit, L. G. Burdelya, E. Samoylova, A. V. Khodyakova, R. Ganapathi, M. Ganapathi, N. D. Tararova, et al. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-{kappa}B-dependent mechanism of p53 suppression in tumors PNAS, November 29, 2005; 102(48): 17448 - 17453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |